Life Science News

RSS

Researchers identify immune cell receptor that drives organ aging process

We may age at different rates, but none of us escapes aging. A study in mice and in human cells by Stanford Medicine researchers pins much of the blame on a particular type of immune cell's increased inability, with advancing age, to gobble up another immune cell type.

16 Jul 2026

Specialized dendritic cells found to coordinate antitumor immunity

Researchers at the Icahn School of Medicine at Mount Sinai have identified the immune cell that acts as the architect and coordinator of powerful immune hubs that form inside tumors and plays a key role in antitumor immunity.

16 Jul 2026

Study suggests lipid droplet accumulation is a conserved feature of senescent cells

A new research paper was published in Volume 18 of Aging on July 1, 2026, titled "Senescent cells accumulate lipid droplets."

16 Jul 2026

New method detects early skin collagen damage before visible signs

An international team led by researchers at Hiroshima University has developed a new way to detect subtle, early-stage changes in human skin collagen before any visible signs of damage appear.

16 Jul 2026

Hamilton dissolved oxygen sensors achieve North American Ex approval for hazardous environments

Hamilton today announced that its VisiFerm mA and VisiTrace mA dissolved oxygen sensors have received North American Ex approval, enabling safe operation in hazardous and explosive environments across the United States and Canada.

From Hamilton Process Analytics 16 Jul 2026

Hamilton is accredited as a manufacturer of certified reference materials in accordance with ISO 17034

Hamilton was recently accredited as a manufacturer of certified reference materials in accordance with ISO 17034.

From Hamilton Process Analytics 16 Jul 2026

Walking protein structure explains how cells activate molecular motors

A nerve cell resembles a vast tree with branches that communicate with thousands of other cells. To function, it depends on a motor protein that walks on two legs, hauling urgent cargo from the center of the cell to the faraway tips of every branch.

15 Jul 2026

Genome-mining tool reveals new antibiotic hidden in a silent gene cluster

Researchers developed DiscERN, a genome-mining platform that combines four complementary algorithms to identify evolutionarily related biosynthetic gene clusters and prioritize candidates for experimental study. The approach revealed discomycin A, a previously unknown calcium-dependent lipopeptide antibiotic with potent activity against several Gram-positive bacteria.

15 Jul 2026

Fruit fly study uncovers gene behind seasonal winter dormancy

Researchers at Washington State University have discovered a molecular "winter lock" that keeps animals in a less active winter state until favorable conditions return, a discovery that could improve pest control and lead to a better understanding of seasonal health conditions in humans.

15 Jul 2026

Life sciences leaders face urgent workforce redesign challenge as AI reshapes productivity, skills and operating models

AI's impact on drug discovery and manufacturing raises critical workforce questions, driving life sciences organizations to rethink skills and leadership.

From Designing the AI-Enabled Life Sciences Workforce Summit Europe 15 Jul 2026

Thermo Fisher Scientific launches GENESYS™ G5 suite of spectrophotometers, combining UV-Vis performance with expandable software and workflow flexibility

Thermo Fisher Scientific has launched the Thermo Scientific™GENESYS™ G5 series of Visible and UV-Visible spectrophotometers, designed to help laboratories standardize workflows, simplify routine testing, and expand analytical capabilities as requirements evolve.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 15 Jul 2026

How to connect make and test for faster drug discovery

Discover how connecting make and test workflows can accelerate drug discovery by improving decision-making across the DMTA cycle.

From TTP plc 15 Jul 2026

Building the next generation of DMTA for future-ready drug discovery

Discover how the next generation of DMTA is creating a future-ready drug discovery engine through AI and automation.

From TTP plc 15 Jul 2026

How to overcome purification bottlenecks in modern drug discovery

Learn how to overcome purification bottlenecks in modern drug discovery with advanced purification strategies, streamlined workflows, and automation.

From TTP plc 15 Jul 2026

Unlocking the potential of organoids in modern drug discovery

Explore how organoids are unlocking new possibilities in modern drug discovery by improving disease modelling within DMTA-driven research workflows.

From TTP plc 15 Jul 2026

Study maps how macrophages age across different body tissues

Why does the immune system become less effective as we age? A new USC study published in BMC Biology offers fresh insights by examining a key immune cell type across tissues: macrophages.

14 Jul 2026

Insilico and Bora Pharmaceuticals forge strategic AI-driven drug discovery alliance

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced a multi-target strategic alliance with Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing.

14 Jul 2026

New imaging method reveals hidden molecular interactions in cells

Cells are crowded, dynamic places where thousands of molecules interact in tight quarters. Until now, scientists lacked a reliable way to see many of these molecular interactions as they happen.

14 Jul 2026

Cell death crosstalk network drives acute respiratory distress syndrome

Acute respiratory distress syndrome (ARDS) remains one of the deadliest complications of severe infections, sepsis, trauma, and viral pneumonia, yet decades of research have produced few targeted therapies capable of improving patient outcomes.

14 Jul 2026

EpilepsyGTx partners with ClearPoint Neuro to support targeted delivery of lead gene therapy in epilepsy

EpilepsyGTx, a biotechnology company developing cutting-edge gene therapies to treat refractory epilepsy, and ClearPoint Neuro ("ClearPoint"), a global therapy-enabling company offering precise navigation and delivery to the brain, today announced a partnership to support the targeted delivery of EpilepsyGTx's lead gene therapy candidate, EPY201, for focal refractory epilepsy (FRE).

From EpilepsyGTx 14 Jul 2026